Literature DB >> 24373770

Structural basis of prion inhibition by phenothiazine compounds.

Pravas Kumar Baral1, Mridula Swayampakula1, Manoj Kumar Rout1, Nat N V Kav2, Leo Spyracopoulos1, Adriano Aguzzi3, Michael N G James4.   

Abstract

Conformational transitions of the cellular form of the prion protein, PrP(C), into an infectious isoform, PrP(Sc), are considered to be central events in the progression of fatal neurodegenerative diseases known as transmissible spongiform encephalopathies. Tricyclic phenothiazine compounds exhibit antiprion activity; however, the underlying molecular mechanism of PrP(Sc) inhibition remains elusive. We report the molecular structures of two phenothiazine compounds, promazine and chlorpromazine bound to a binding pocket formed at the intersection of the structured and the unstructured domains of the mouse prion protein. Promazine binding induces structural rearrangement of the unstructured region proximal to β1, through the formation of a "hydrophobic anchor." We demonstrate that these molecules, promazine in particular, allosterically stabilize the misfolding initiator-motifs such as the C terminus of α2, the α2-α3 loop, as well as the polymorphic β2-α2 loop. Hence, the stabilization effects of the phenothiazine derivatives on initiator-motifs induce a PrP(C) isoform that potentially resists oligomerization.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24373770     DOI: 10.1016/j.str.2013.11.009

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  20 in total

1.  Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods.

Authors:  Lanlan Li; Wei Wei; Wen-Juan Jia; Yongchang Zhu; Yan Zhang; Jiang-Huai Chen; Jiaqi Tian; Huanxiang Liu; Yong-Xing He; Xiaojun Yao
Journal:  J Comput Aided Mol Des       Date:  2017-11-20       Impact factor: 3.686

Review 2.  Transition of the prion protein from a structured cellular form (PrPC ) to the infectious scrapie agent (PrPSc ).

Authors:  Pravas K Baral; Jiang Yin; Adriano Aguzzi; Michael N G James
Journal:  Protein Sci       Date:  2019-10-25       Impact factor: 6.725

3.  Multimodal small-molecule screening for human prion protein binders.

Authors:  Andrew G Reidenbach; Michael F Mesleh; Dominick Casalena; Sonia M Vallabh; Jayme L Dahlin; Alison J Leed; Alix I Chan; Dmitry L Usanov; Jenna B Yehl; Christopher T Lemke; Arthur J Campbell; Rishi N Shah; Om K Shrestha; Joshua R Sacher; Victor L Rangel; Jamie A Moroco; Murugappan Sathappa; Maria Cristina Nonato; Kong T Nguyen; S Kirk Wright; David R Liu; Florence F Wagner; Virendar K Kaushik; Douglas S Auld; Stuart L Schreiber; Eric Vallabh Minikel
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

4.  The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.

Authors:  Danzhi Huang; Amedeo Caflisch
Journal:  Prion       Date:  2015       Impact factor: 3.931

5.  Prion Protein-Antibody Complexes Characterized by Chromatography-Coupled Small-Angle X-Ray Scattering.

Authors:  Lester Carter; Seung Joong Kim; Dina Schneidman-Duhovny; Jan Stöhr; Guillaume Poncet-Montange; Thomas M Weiss; Hiro Tsuruta; Stanley B Prusiner; Andrej Sali
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

6.  Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase.

Authors:  Catarina Coelho; Alessandro Foti; Tobias Hartmann; Teresa Santos-Silva; Silke Leimkühler; Maria João Romão
Journal:  Nat Chem Biol       Date:  2015-08-31       Impact factor: 15.040

7.  A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.

Authors:  Carol L Ladner-Keay; Li Ross; Rolando Perez-Pineiro; Lun Zhang; Trent C Bjorndahl; Neil Cashman; David S Wishart
Journal:  Prion       Date:  2018-10-09       Impact factor: 3.931

Review 8.  Successes and challenges in phenotype-based lead discovery for prion diseases.

Authors:  Sina Ghaemmaghami; Miranda Russo; Adam R Renslo
Journal:  J Med Chem       Date:  2014-04-24       Impact factor: 7.446

9.  Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches.

Authors:  Jae Wook Hyeon; Jiwon Choi; Su Yeon Kim; Rajiv Gandhi Govindaraj; Kyu Jam Hwang; Yeong Seon Lee; Seong Soo A An; Myung Koo Lee; Jong Young Joung; Kyoung Tai No; Jeongmin Lee
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

10.  A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.

Authors:  Tania Massignan; Sara Cimini; Claudia Stincardini; Milica Cerovic; Ilaria Vanni; Saioa R Elezgarai; Jorge Moreno; Matteo Stravalaci; Alessandro Negro; Valeria Sangiovanni; Elena Restelli; Geraldina Riccardi; Marco Gobbi; Joaquín Castilla; Tiziana Borsello; Romolo Nonno; Emiliano Biasini
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.